Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the radiopharmaceutical company ITM Isotope Technologies…
The Paris-Munich Epigenetics Workshop & Symposium organized by Dr. Till Bartke from the Institute of Functional Epigenetics will take place at the Max Planck Institute of Biochemistry in Munich on June 14-16, 2023.
Amyotrophic Lateral Sclerosis (ALS) is a non-curable degenerative disease of the motor nervous system. The cause of the disease is largely unknown: In addition to genetic factors, viruses are also suspected to be involved in the development of the…
On January 1, 2023, the new independent research unit “Signaling & Translation” (SAT) was established at Helmholtz Munich under the leadership of Daniel Krappmann. As part of the “Molecular Targets and Therapeutics Center” (MTTC), SAT investigates…
The Gordon Research Conference "Chromatin Modifications in Health and Disease", co-organised by Robert Schneider, will take place from June 11-16,2023, at Bryant University in Rhode Island. The deadline for abstract submission is on May 14, 2023.
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
